Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pouteau

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Gastroenterologie Clinique Et Biologique|December 1, 1995
[Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives]P Marcellin, M Pouteau, M Martinot, et al.
The Journal of Infectious Diseases|March 1, 1993
Retreatment with recombinant interferon-alpha in patients with chronic hepatitis CP Marcellin, M Pouteau, N Boyer, et al.
Lancet (London, England)|March 2, 1991
Second generation (RIBA) test in diagnosis of chronic hepatitis CP Marcellin, M Martinot-Peignoux, N Boyer, et al.
Gut|June 1, 1992
Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis CP Marcellin, M Pouteau, P Renard, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CM Martinot-Peignoux, P Marcellin, M Pouteau, et al.
Clinical Endocrinology|December 1, 1993
Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis CE Baudin, P Marcellin, M Pouteau, et al.
Journal of Viral Hepatitis|July 5, 2016
Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patientsM Martinot-Peignoux, M Lapalus, S Maylin, et al.
Gastroenterology|July 1, 1995
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis CP Marcellin, M Pouteau, M Martinot-Peignoux, et al.
Annals of Internal Medicine|February 12, 1998
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapyP Marcellin, N Boyer, A Gervais, et al.
Gut|March 1, 1995
Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replicationP Marcellin, M Pouteau, M A Loriot, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Gastroenterologie Clinique Et Biologique|December 1, 1995
[Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives]P Marcellin, M Pouteau, M Martinot, et al.
The Journal of Infectious Diseases|March 1, 1993
Retreatment with recombinant interferon-alpha in patients with chronic hepatitis CP Marcellin, M Pouteau, N Boyer, et al.
Lancet (London, England)|March 2, 1991
Second generation (RIBA) test in diagnosis of chronic hepatitis CP Marcellin, M Martinot-Peignoux, N Boyer, et al.
Gut|June 1, 1992
Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis CP Marcellin, M Pouteau, P Renard, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CM Martinot-Peignoux, P Marcellin, M Pouteau, et al.
Clinical Endocrinology|December 1, 1993
Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis CE Baudin, P Marcellin, M Pouteau, et al.
Journal of Viral Hepatitis|July 5, 2016
Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patientsM Martinot-Peignoux, M Lapalus, S Maylin, et al.
Gastroenterology|July 1, 1995
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis CP Marcellin, M Pouteau, M Martinot-Peignoux, et al.
Annals of Internal Medicine|February 12, 1998
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapyP Marcellin, N Boyer, A Gervais, et al.
Gut|March 1, 1995
Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replicationP Marcellin, M Pouteau, M A Loriot, et al.
Pageof 3